Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication.
Pathogens
; 13(4)2024 Mar 25.
Article
em En
| MEDLINE
| ID: mdl-38668233
ABSTRACT
The eradication of the hepatitis C virus (HCV) has revolutionized the hepatology paradigm, halting the progression of advanced liver disease in patients with chronic infection and reducing the risk of hepatocarcinoma. In addition, treatment with direct-acting antivirals can reverse the lipid and carbohydrate abnormalities described in HCV patients. Although HCV eradication may reduce the overall risk of vascular events, it is uncertain whether altered lipid profiles increase the risk of cerebrovascular disease in certain patients. We have conducted a review on HCV and lipid and carbohydrate metabolism, as well as new scientific advances, following the advent of direct-acting antivirals.
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
Base de dados:
MEDLINE
Idioma:
En
Revista:
Pathogens
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Espanha